The therapy is being examined as a potential oral adjunctive treatment to insulin for type 1 diabetes. Credit: ANDREI ASKIRKA/Shutterstock. · Clinical Trials Arena · ANDREI ASKIRKA/Shutterstock. The ...
JPM's mid-July Q2 earnings and UNH's medical cost ratio are the two fund-specific triggers that could quickly unwind VTV's ...
Vanguard Value Index Fund ETF is downgraded to Strong Sell due to limited upside and macroeconomic risks. VTV trades at a trailing P/E of 21.1x and P/B of 3.1x, cheaper than the S&P 500 but with lower ...
A 50/50 allocation of US large-cap and US small-cap value outperforms US large-cap value in risk-adjusted returns. AVLV offers better value factor loadings and historically superior returns compared ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results